We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Optilume® drug-coated balloon dilation in complex female urethral stricture
PeriodicalsMedical Sciences

Optilume® drug-coated balloon dilation in complex female urethral stricture

Checking your access to this record.

Abstract & Overview

The treatment of female urethral stricture disease is in flux in terms of developing guidelines for surgical treatment. Urethral strictures in women are rare, but frequently result because of urethral instrumentation or surgery. Stricture sites vary from proximal, intrasphincteric, distal or at the meatus. Stricture formation after previous urethral surgery may pose a special challenge. We describe the first Optilume® urethral drug-coated balloon dilation for female urethral stricture disease involving the sphincter. After six months follow-up the patient remains stricture free with full continence and complete bladder emptying.

Cite this record

Jannik Stuehmeier, Lukas Andrius Jelisejevas, Patricia Kink, Alexandra Gulacsi, Wolfgang Horninger, Peter Rehder (2021). Optilume® drug-coated balloon dilation in complex female urethral stricture. Urology Case Reports, 41, 101987–101987. https://doi.org/10.1016/j.eucr.2021.101987

Copy in another style

Stuehmeier, J., Jelisejevas, L. A., Kink, P., Gulacsi, A., Horninger, W., & Rehder, P. (2021). Optilume® drug-coated balloon dilation in complex female urethral stricture. Urology Case Reports, 41, 101987–101987. https://doi.org/10.1016/j.eucr.2021.101987
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.